EULAV Asset Management’s Select Medical SEM Stock Holding History

EULAV Asset Management’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-70,528	Closed	-$912K	–	224
2022 Q1	$912K	Hold	70,528	–	–	0.03%	211
2021 Q4	$1.12M	Hold	70,528	–	–	0.03%	215
2021 Q3	$1.37M	Buy	70,528 +9,280	+15%	+$184K	0.04%	205
2021 Q2	$1.4M	Buy	61,248 +18,560	+43%	+$385K	0.04%	206
2021 Q1	$784K	Buy	+42,688	New	+$700K	0.02%	232

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EULAV Asset Management's SEM Position: Q2 2022 in Review

EULAV Asset Management sold out of Select Medical (SEM) in Q2 2022, closing a stake of 70,528 shares — an estimated $912K sold.

EULAV Asset Management first reported a position in SEM in Q1 2021 and held it in 5 quarters. The position peaked at $1.4M in Q2 2021. 217 funds tracked by Wall St. Rank hold SEM as of Q2 2022.

EULAV Asset Management reported no remaining Select Medical position as of Q2 2022 after selling out during the quarter.
EULAV Asset Management sold 70,528 Select Medical shares in Q2 2022, an estimated $912K.
EULAV Asset Management first reported a position in Select Medical in Q1 2021 and held it in 5 quarters.
EULAV Asset Management's Select Medical position peaked at $1.4M in Q2 2021.
217 funds tracked by Wall St. Rank held Select Medical as of Q2 2022.

Based on EULAV Asset Management's 13F filing for Q2 2022, filed 22 Jul 2022.